Literature DB >> 10882592

Group B streptococcal beta-hemolysin induces nitric oxide production in murine macrophages.

A Ring1, J S Braun, V Nizet, W Stremmel, J L Shenep.   

Abstract

Group B streptococcus (GBS) is the leading cause of sepsis in neonates. Nitric oxide (NO) release plays a role in the hypotension that characterizes septic shock. To examine the role of the GBS beta-hemolysin in NO production, the murine macrophage line RAW 264. 7 was exposed to a wild-type (WT) GBS isolate and to hyperhemolytic (HH) and nonhemolytic (NH) transposon mutants derived from that isolate. After activation of macrophages by the WT strain, the HH mutant, or cell-free extracts of beta-hemolysin, nitrite release into the supernatant increased >10-fold and inducible NO synthase (iNOS) levels in cell lysates increased up to 10-fold compared with treatment with the NH mutant or extracts from that mutant. Hemolysin-induced NO production was dependent on protein tyrosine kinases and NF-kappaB, but not on extracellular signal-related kinase-1/2-mitogen-activated kinases or protein kinase A. These results indicate that GBS beta-hemolysin induces murine macrophage iNOS via intracellular pathways similar to those that mediate lipopolysaccharide-induced iNOS activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882592     DOI: 10.1086/315681

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

2.  Cytokine responses to group B streptococci induce nitric oxide production in respiratory epithelial cells.

Authors:  Kenneth J Goodrum; Jane Poulson-Dunlap
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 3.  Aspects of eukaryotic-like signaling in Gram-positive cocci: a focus on virulence.

Authors:  Kellie Burnside; Lakshmi Rajagopal
Journal:  Future Microbiol       Date:  2011-07       Impact factor: 3.165

4.  Activation of the NLRP3 inflammasome by group B streptococci.

Authors:  Alessandro Costa; Rahul Gupta; Giacomo Signorino; Antonio Malara; Francesco Cardile; Carmelo Biondo; Angelina Midiri; Roberta Galbo; Patrick Trieu-Cuot; Salvatore Papasergi; Giuseppe Teti; Philipp Henneke; Giuseppe Mancuso; Douglas T Golenbock; Concetta Beninati
Journal:  J Immunol       Date:  2012-01-16       Impact factor: 5.422

5.  Threonine phosphorylation prevents promoter DNA binding of the Group B Streptococcus response regulator CovR.

Authors:  Wan-Jung Lin; Don Walthers; James E Connelly; Kellie Burnside; Kelsea A Jewell; Linda J Kenney; Lakshmi Rajagopal
Journal:  Mol Microbiol       Date:  2009-01-23       Impact factor: 3.501

6.  Novel observation of hot-cold-hot hemolysis exhibited by group B streptococci.

Authors:  Norio Okazaki; Ro Osawa; Rieko Suzuki; Takayasu Nikkawa; Robert A Whiley
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 7.  Understanding the regulation of Group B Streptococcal virulence factors.

Authors:  Lakshmi Rajagopal
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

8.  Distinct Group B Streptococcus Sequence and Capsule Types Differentially Impact Macrophage Stress and Inflammatory Signaling Responses.

Authors:  Rebecca A Flaherty; David M Aronoff; Jennifer A Gaddy; Margaret G Petroff; Shannon D Manning
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

9.  Bacterial phenotype variants in group B streptococcal toxic shock syndrome.

Authors:  Parham Sendi; Linda Johansson; Samira Dahesh; Nina M Van-Sorge; Jessica Darenberg; Mari Norgren; Jan Sjölin; Victor Nizet; Anna Norrby-Teglund
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.